Introduction {#S1}
============

Dopamine (DA) as a neurotransmitter or neuromodulator plays important roles in many brain functions including motor control, motivation, reward, cognition, maternal and reproductive behaviors ([@B6]; [@B31]). DA actions are mediated by G protein-coupled receptors, which are classified into two major types based on their gene sequence homology and functions: the excitatory D1-like (D1LRs) and inhibitory D2-like (D2LRs) receptors ([@B4]). In the mammalian brain DA-containing neurons are located in several distinctive cell groups distributed from the mesencephalon to the olfactory bulb (OB) ([@B15]; [@B7]).

In the OB, DA is exclusively released by a population of interneurons termed short axon cells (SACs), which express glutamic acid decarboxylase (GAD) 67, a key enzyme for biosynthesis of the inhibitory neurotransmitter GABA ([@B32]; [@B30]). Both D1LRs and D2LRs are present in the OB with distinct distribution patterns, i.e., D1LRs are broadly present from glomerular to granule cell layers while D2LRs are confined only to the superficial olfactory nerve (ON) and the glomerular layers ([@B23]; [@B34]; [@B13]; [@B24]; [@B62]). Pharmacological activation of D2LRs ([@B45]; [@B27]; [@B18]; [@B40]; [@B42]) or optogenetic activation of SACs inhibits glutamate release from ON terminals to postsynaptic cellular targets in the glomerular layer ([@B58]). Moreover, *in vivo* studies showed that blocking either D1LRs or D2LRs ([@B19]) or lack of DA transporters or D2LRs impairs odor discrimination in animals ([@B57]; [@B56]) whereas olfactory deprivation upregulates D2LR density in the OB ([@B23]). Interestingly, a mating-triggered DA surge in the main OB of female mice impairs their perception of social odors contained in male urine ([@B52]). Additionally, dopaminergic SACs exhibit high level of activity-dependent plasticity. For example, naris closure leads to a drastic reduction in the number of TH-immunoreactive cells and processes ([@B12]; [@B47]; [@B33]; [@B8]). Furthermore, majority of DAergic SACs originate from postnatal neurogenesis and are continuously subject to replenishment during adult life ([@B33]; [@B8]). All these previous findings suggest that DA actively participates in modulating signal processing in the OB. However, the mechanistic actions of DA at the cellular and circuit levels in the OB are not well understood.

The DAergic/GABAergic SACs have somata and processes confined to the glomerular layer ([@B32]; [@B30]), where excitatory and inhibitory circuits are formed among the axonal terminals of olfactory sensory neurons (OSNs), apical dendrites of ETCs and the OB output neurons mitral and tufted cells (MTCs), and two major populations of inhibitory interneurons types -- SACs and periglomerular cells (PGCs) ([@B37]; [@B61]; [@B43]; [@B10]; [@B48]). Thus, the DAergic/GABAergic SACs are well-situated to modulate olfactory signal processing at the initial site of synaptic integration in the whole olfactory system. Physiological evidence suggests that functional operation of the SAC-derived circuit depends on postsynaptic cellular targets. For instance, DA is coreleased with GABA from SACs to mediate a biphasic excitatory-inhibitory sequential response in ETCs ([@B35]) while the transmission from SACs to MTCs or PGCs is mediated by GABAergic and electrical synapses ([@B3]; [@B36]) or GABA alone but not by DA ([@B55]). Alternatively, DA potentially functions as a neuromodulator in the OB through volume transmission ([@B14]). A recent study revealed that DA release from SACs in the OB was quantal and calcium-dependent but was asynchronous and lasted for tens of seconds ([@B9]), supporting volume transmission. Thus, in the present study we designed experiments to examine actions of exogenous DA on both excitatory and inhibitory transmission in the glomerular circuit and analyzed the underlying cellular mechanisms.

Materials and Methods {#S2}
=====================

Animals {#S2.SS1}
-------

Both male and female C57BL/6J mice were purchased from Charles River. The GAD2gfp mice provided of courtesy by Dr. Gabor Szabo were initially from the GAD65_3e/gfp5.5 \#30 line on a genetic background of C57BL6 backcrossed to B6CBAF1/J wild-type mice to generate the transgene heterozygotes ([@B38]). TH-GFP mice were initially courtesy of Dr. Kobayashi ([@B41]) and generated using a 9.0 kb 5′-flanking region of the TH gene on a genetic background of C57BL/6J to crossbreed with DBA/2J mice. These TH-GFP transgenic mice were then backcrossed to C57BL/6J mice to generate heterozygotes for experimental usage. All animals were maintained with a standard 12-h light/dark cycle with *ad libitum* access to food and water. All experimental procedures were carried out in accordance with protocols submitted to and approved by the Howard University Institutional Animal Care and Use Committee.

Slice Preparation {#S2.SS2}
-----------------

Acute OB slices were prepared from 6- to 8-week-old male or female mice as described previously ([@B35]). Briefly, horizontal slices (350 μm) were cut with a VT1200s vibratome (Nussloch, Germany) in an ice-cold and oxygenated (95% O~2~--5% CO~2~) sucrose-based artificial CSF (sucrose-ACSF) containing (in mM) 210 sucrose, 3 KCl, 1.2 NaH~2~PO~4~, 2.6 MgSO~4~, 0.5 CaCl~2~, 26 NaHCO~3~, 10 glucose. After 30 min incubation in normal ACSF at 30°C, slices were then transferred to ACSF at room temperature until they were used for recordings. Normal ACSF was continuously bubbled with 95% O~2~--5% CO~2~ and had the following composition (in mM): 124 NaCl, 3 KCl, 1.25 NaH~2~PO~4~, 2.0 MgSO~4~, 2.0 CaCl~2~, 26 NaHCO~3~, 10 glucose. During experiments, slices were perfused at 3 ml/min with ACSF equilibrated with 95% O~2~--5% CO~2~ and warmed to 30°C.

Electrophysiology {#S2.SS3}
-----------------

Whole cell patch clamp recordings were made from OB neurons visualized using Axio Examiner (Zeiss, Oberkochen, Germany) fixed-stage upright microscope with near-infrared differential interference contrast (DIC) optics. Short axon (SACs) and periglomerular cells (PGCs) were identified by their expression of TH- or GAD65-EGFP in corresponding transgenic mice, respectively.

External tufted cells (ETCs) were initially reported in previous studies with Golgi staining ([@B51]; [@B49], [@B50]; [@B39]). Recent work more rigorously characterized the morphological and electrophysiological properties of ETCs ([@B26]; [@B1]). Based on findings from these studies, we redefined and identified ETCs with the following criteria: (1) spontaneous and intrinsic burst spiking that is resistant to blockers of fast synaptic transmitter receptors; (2) soma residing in the deep half of the glomerular layer with "pear" appearance viewed in near-IR DIC optics; (3) an apical dendrite tuft extensively ramifying in a single glomerulus but lack of lateral dendrites in the external plexiform layer (EPL).

To localize apical dendrite tufts of the recorded mitral/tufted cells (MTCs) in the glomerular layer, Alexa-594 (10 μM) was added to the recording electrode solution. Whole cell current or voltage signals were recorded with a MultiClamp 700B amplifier (Molecular Devices, Palo Alto, CA, United States) and low-pass filtered at 4 kHz and sampled at 10 kHz with a DIGIDATA 1550B 16-bit analog-to-digital converter (Molecular Devices) using Clampex 11.0.3 (Molecular Devices). Patch recording electrodes were pulled from standard-wall glass capillary tubes without filament (Sutter Instrument, Novato, CA, United States). Patch pipettes (4--7 MΩ) for whole cell current clamp recording contained (in mM) 115 K-gluconate, 5.0 EGTA, 0.63 CaCl~2~, 5.5 MgCl~2~, 10 HEPES, 3 Na~2~-ATP, 0.3 Na~3~-GTP, and 14 Tris-phosphocreatine (pH 7.3, 285--295 mOsm). Voltage clamp recordings of spontaneous excitatory (sEPSCs) or inhibitory postsynaptic currents (sIPSCs) were made with internal solution containing (in mM) 133 CsCH~3~O~3~S, 3 EGTA, 0.4 CaCl~2~, 5 QX-314, 4 MgCl~2~, 10 HEPES, 3 Na~2~-ATP, 0.3 Na~3~-GTP (pH 7.3, 285--295 mOsm). Cells were voltage clamped at −70 mV, the reversal potential of Cl^--^, to minimize the Cl-mediated sIPSCs thus to optimize the recording of sEPSCs. Cells were voltage clamped at 0 mV, the reversal potential of AMPA and NMDA receptor-mediated sEPSCs, to optimize recording of sIPSCs. Before bath application of the GABA~A~ receptor blocker gabazine (GBZ), NBQX (10 μM) and APV (50 μM) were pre-applied to block fast glutamate receptors thus preventing epileptic activity.

Electrical Stimulation {#S2.SS4}
----------------------

Electrical stimulation was delivered by bipolar glass electrodes made from theta borosilicate tubes (Sutter Instrument). The isolated and constant current stimulation pulses (100 μs) were triggered by a Master-9 stimulator (AMPI, Jerusalem, Israel).

Data Analysis {#S2.SS5}
-------------

Amplitudes and frequencies of sEPSCs or sIPSCs were measured with Wdetecta.^[1](#footnote1){ref-type="fn"}^ Drug effects on sEPSCs and sIPSCs were determined by measuring these parameters from 1 min duration traces taken immediately before or 1 min (micropuffing) or 2 min (bath application) after drug application in each condition for each cell. Other data were measured and analyzed with Clampfit 11.0.3 (Molecular Devices) and Origin Pro 2019 (Origin Lab, Northampton, MA, United States). Statistical significance of population responses was calculated by using paired Student's *t*-test or ANOVA One-way repeated measure with Bonferroni *post hoc* comparisons in Origin Pro 2019.

Drugs Delivery and Chemicals {#S2.SS6}
----------------------------

Drugs were applied by either bath perfusion to treat the whole slices or micropuffing to target the relevant glomeruli by 2 ms and 30 psi pneumatic pressure generated by a picospritzer (Parker Instruments, Cleveland, OH, United States). Micropuffing pipettes were made from thick wall borosilicate glass capillaries without filament (Sutter Instrument) with a 6-μm tip diameter. These parameters were calibrated to deliver an injection volume of ∼20 nl and were previously shown to deliver drug coverage restricted to a single glomerulus ([@B54]).

D-2-Amino-5-phosphonopentanoic acid sodium salt (APV, 50 μM), 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo\[f\]quinoxaline-7-sulfonamide disodium salt (NBQX disodium salt, 10 μM), Gabazine (SR95531, 10 μM), 8-Bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol hydrobromide (SKF83566 bromide, 10 μM), (S)-(-)-5-Aminosulfonyl-*N*-\[(1-ethyl-2-pyrrolidinyl)methyl\]-2-methoxybenzamide \[(S)-(-)-Sulpiride, 100 μM\], (2S)-3-\[\[(1S)-1-(3,4-Dichlorophenyl)ethyl\]amino-2-hydroxypropyl\](phenylmethyl)phosphinic acid hydrochloride (CGP55845 hydrochloride, 10 μM) were purchased from Tocris Cookson (Ellisville, MO, United States). Dopamine chloride (DA, 20 μM or 100 μM) and all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, United States). All drugs were dissolved in distilled water as stock solution and diluted 1000 times with ACSF to final concentrations.

Results {#S3}
=======

Dopamine Inhibits Spontaneous EPSCs in Glomerular Interneurons via D1LRs {#S3.SS1}
------------------------------------------------------------------------

Previous studies have shown that optogenetic activation of SACs leads to GABA and DA corelease ([@B35]). The coreleased GABA and DA orchestrate to modulate ETC physiological behaviors in such a way that DA enhances *I*~h~ to boost the rebound excitation following the GABA~A~ receptor-mediated inhibition ([@B35]). Consistently, exogenous DA increases the *I*~h~-dependent bursts of action potentials in ETCs. As a major excitatory element in the glomerular circuit, ETCs monosynaptically drive vast majority of the inhibitory periglomerular cells (PGCs) and SACs ([@B53]; [@B30]). All these findings lead us to predict that DA increases spontaneous excitatory synaptic activities in the ETC-driven PGCs and SACs. To test this, we recorded sEPSCs in PGCs and SACs in OB slices under voltage clamp and examined effects of exogenous DA. As PGCs and SACs exclusively express the key enzyme of GABA biosynthesis GAD65 and the rate-limiting enzyme of dopamine biosynthesis tyrosine hydroxylase (TH), respectively ([@B30]), PGCs and SACs were accordingly identified in GAD65-GFP ([Figure 1A](#F1){ref-type="fig"}) and TH-GFP (not shown) mice. To differentiate the ON-driven and ETC-driven PGCs and SACs, we started with recording their responses to ON stimulation. Consistent with previous findings ([@B53]; [@B30]), vast majority of PGCs (8/13) or SACs (8/12) respond to ON-stimulation with long and inconsistent latencies (4.3 ± 0.31 ms, *n* = 8 PGCs; 4.6 ± 0.42, *n* = 8 SACs) EPSCs and exhibit bursts of sEPSCs ([Figures 1B,C](#F1){ref-type="fig"}), indicating that they are ETC-driven glomerular interneurons. The rest PGCs (5/13) and SACs (4/12) responded to ON stimulation with short latencies (2.3 ± 0.15 ms, *n* = 5 PGCs; 2.1 ± 0.17, *n* = 4 SACs), suggesting that they are ON-driven glomerular interneurons. Surprisingly, bath application of DA reversibly suppressed sEPSCs in all tested PGCs (*n* = 13, [Figures 1C--F,H](#F1){ref-type="fig"}) and SACs (*n* = 12). sEPSC frequency and amplitude in PGCs (*n* = 13) were 63.0 ± 6.7 Hz and 57.4 ± 5.0 pA in ACSF, 29.2 ± 3.0 Hz (*P* \< 0.0001 vs. in ACSF) and 32.3 ± 3.4 pA (*P* \< 0.0001 vs. in ACSF) in DA (20 μM), and 61.3 ± 6.3 Hz (*P* = 1 vs. in ACSF) and 55.7 ± 5.0 pA (*P* = 1 vs. in ACSF) after DA washout. Similarly, sEPSC frequency and amplitude in 12 SACs were 64.3 ± 8.4 Hz and 71.0 ± 9.0 pA in ACSF, 28.8 ± 3.6 (*P* \< 0.0001 vs. ACSF) and 37.4 ± 4.3 pA Hz (*P* \< 0.0001 vs. ACSF) in DA, 63.6 ± 8.5 Hz (*P* = 1 vs. ACSF) and 70.3 ± 8.8 pA (*P* = 1 vs. ACSF) after DA washout ([Figures 1I,K](#F1){ref-type="fig"}). While the DA suppression of sEPSCs in the ON-driven PGCs and SACs is consistent with previous findings that DA inhibits glutamate release from the ON terminals ([@B27]; [@B5]; [@B18]; [@B40]; [@B58]), the similar DA action on the ETC-driven PGCs and SACs may indicate dopaminergic modulation of glutamate release from ETC apical dendritic terminals in the glomerular layer. Given that burst sEPSCs reflect spontaneous burst firing activities in presynaptic ETCs, we also measured the sEPSC burst frequencies and found that the frequency of sEPSC bursts was also reduced by DA ([Figures 1G,J](#F1){ref-type="fig"}). sEPSC burst frequencies in PGCs (*n* = 8) and SACs (*n* = 8) were 6.1 ± 1.0 Hz and 7.8 ± 1.1 Hz in ACSF, 4.1 ± 0.7 Hz (*P* \< 0.0001 vs. ACSF) and 5.3 ± 0.8 Hz (*P* \< 0.0001 vs. ACSF) in DA, 6.1 ± 0.9 Hz (*P* = 1 vs. ACSF) and 7.7 ± 1.0 Hz (*P* = 1 vs. ACSF) after DA washout, respectively. Collectively, these results indicate that DA inhibits glutamate release from presynaptic ETC apical dendrites to PGCs and SACs thus reduces burst sEPSCs.

![DA suppresses sEPSCs in glomerular interneurons. **(A)** Photo graph showing GFP-expressing periglomerular cells (PGCs) in the glomerular layer of an OB slice prepared from a GAD65-GFP mouse. **(B)** Typical excitatory postsynaptic current (EPSCs) traces in a PGC evoked by stimulation of the olfactory nerves (ON-stim.). Note that EPSC onset latencies are longer than 3 ms and varies among traces. **(C)** A representative voltage clamp recording trace showing that bath-applied DA (20 μM, red horizontal bar) reduces both frequency and amplitude of spontaneous burst EPSCs in a PGC (top). Middle and bottom traces are blown-up. **(D,E)**: plotting graphs showing changes in instant frequency **(D)** and amplitude **(E)** of sEPSCs before, during and after DA application in the same trace in **(C)**. **(F--H)** Line graphs of cumulative probability (Cumul. P.) against frequency of individual **(F)** or burst **(G)** sEPSCs, or amplitude (Ampl., **H**) of individual sEPSCs before (control), during (DA), and after (wash) DA application. **(I--K)** Pooled data showing that DA reduces both frequency of individual **(I)** or burst **(J)** sEPSCs and amplitude **(K)** of sEPSCs in both PGCs (*n* = 13) and short-axon cells (SACs, *n* = 12).](fncel-14-00172-g001){#F1}

Dopamine actions are mediated by two major categories of G protein-coupled receptors -- D1LRs and D2LRs ([@B4]). Evidence shows that D2LRs in ON terminals mediate presynaptic inhibition of glutamate release to their postsynaptic targets in the glomerular layer ([@B45]; [@B2]; [@B42]). This explains why DA suppresses sEPSCs in the ON-driven PGCs and SACs. All ETCs receive direct ON input ([@B25]; [@B16]; [@B22]), does DA inhibit ON terminals via D2LRs to reduce ETC burst firing thus indirectly suppresses burst sEPSCs in the ETC-driven PGCs and SACs? To test this, we treated OB slices with bath application of (S)-(-)-Sulpiride (100 μM), a selective D2LR antagonist, for 10 min before addition of DA ([Figure 2A](#F2){ref-type="fig"}). In these conditions, DA reduced sEPSC frequency by 46.8 ± 1.9% (*n* = 7) in PGCs and 49.7 ± 1.9% (*n* = 6) in SACs, amplitude by 47.9 ± 3.7% (*n* = 7) in PGCs and 48.3 ± 3.0% (*n* = 6) in SACs ([Figures 2A--C](#F2){ref-type="fig"}) in the presence of (S)-(-)-Sulpiride. Specifically, sEPSC frequency and amplitude in PGCs (*n* = 7) were 76.8 ± 11.9 Hz and 75.1 ± 11.6 pA in (S)-(-)-Sulpiride, 40.3 ± 5.9 Hz \[*P* \< 0.0001 vs. (S)-(-)-Sulpiride\] and 39.0 ± 6.8 pA \[*P* \< 0.0001 vs. (S)-(-)-Sulpiride\] in (S)-(-)-Sulpiride+DA, and 77.4 ± 12.4 Hz \[*P* = 1 vs. (S)-(-)-Sulpiride\] and 74.0 ± 11.7 pA \[*P* = 1 vs. (S)-(-)-Sulpiride\] after washout DA, respectively ([Figures 2D,E](#F2){ref-type="fig"}). Similar results were observed in SACs (*n* = 6) with average frequency and amplitude of 68.2 ± 11.4 Hz and 65.7 ± 12.1 pA in (S)-(-)-Sulpiride, 34.2 ± 6.0 Hz \[*P* \< 0.0001 vs. (S)-(-)-Sulpiride\] and 34.3 ± 6.7 pA \[*P* \< 0.0001 vs. (S)-(-)-Sulpiride\] in the addition of DA, and 67.1 ± 12.0 Hz \[*P* = 1 vs. (S)-(-)-Sulpiride\] and 64.3 ± 11.8 pA \[*P* = 1 vs. (S)-(-)-Sulpiride\] after DA washout ([Figures 2D,E](#F2){ref-type="fig"}). These findings suggest that D2LRs do not mediate presynaptic inhibition of glutamate release from ON terminals to ETCs to PGCs and SACs.

![D1LRs mediate DA actions on sEPSCs in glomerular interneurons. **(A)** A representative recording trace showing DA effects on sEPSCs in a PGC in the presence of 100 μM (S)-(-)-Sulpiride (Sul), a selective D2LR antagonist. **(B,C)** Graphs plotting cumulative probability against frequency **(B)** or amplitude **(C)** of sEPSCs shown in **(A)**. **(D,E)** Pooled data showing that DA reduces both frequency **(D)** and amplitude **(E)** of sEPSCs in both PGCs (*n* = 7) and SACs (*n* = 6) in the presence of (S)-(-)-Sulpiride. **(F)** A representative recording trace showing that DA has no effect on sEPSCs in a PGC in the presence of 10 μM SKF83566 (SKF), a selective D1LR antagonist. **(G,H)** Graphs plotting cumulative probability against frequency **(G)** or amplitude **(H)** of sEPSCs shown in **(F)**. **(I,J)** Pooled data showing that DA has effect on neither frequency **(I)** nor amplitude **(J)** of sEPSCs in either PGCs (*n* = 7) or SACs (*n* = 6) in the presence of SKF83566.](fncel-14-00172-g002){#F2}

Then we examined DA effects on sEPSCs in PGCs and SACs in the presence of the selective D1LR antagonist SKF83566 (10 μM). However, in these conditions, DA altered neither frequency nor amplitude of sEPSCs in either population of glomerular interneurons ([Figures 2F--J](#F2){ref-type="fig"}), implying that the DA suppression of sEPSCs in both PGCs and SACs is mediated by D1LRs.

Altogether, our results support that DA reduces sEPSCs in the ETC-driven PGCs and SACs by activation of D1LRs but this action is not due to reduced ETC activities, which result from activation of D2LRs on ON terminals to reduce glutamate release.

DA Enhances Spontaneous IPSCs in Glomerular Neurons {#S3.SS2}
---------------------------------------------------

Since activation of D1LRs on ETCs produces an excitatory effect ([@B35]) whereas ON terminals are devoid of D1LRs ([@B34]; [@B13]; [@B4]), we hypothesized that the DA via D1LRs directly excites PGCs and/or SACs to release GABA, which activates GABA~B~ receptors on ETC apical dendrites ([@B29]) to reduce glutamate release onto PGCs and SACs. In this scenario, DA should elevate the glomerular inhibition. To test this, we recorded spontaneous inhibitory postsynaptic currents (sIPSCs) in voltage clamp in all three populations of glomerular neurons including PGCs, SACs and ETCs, which all have apical dendrites or processes confined to the glomerular layers thus could manifest potential DA-enhanced glomerular inhibition. To maximize detection sIPSCs, which have reversal potential around −70 mV based on chloride concentrations of our internal and external solutions, and minimize sEPSCs, which have a reversal potential at 0 mV, we voltage clamped cells at 0 mV in the presence of NBQX (10 μM) and D-APV (50 μM) to block AMPA and NMDA receptors thus minimize circuit influence. In these conditions, bath application of DA (20 μM) reversibly enhanced sIPSCs in PGCs ([Figure 3A](#F3){ref-type="fig"}). When sIPSCs were completely abolished by the selective GABA~A~ receptor blocker gabazine (GBZ, 10 μM, [Figure 3A](#F3){ref-type="fig"}), DA showed no effect on the holding current, suggesting that DA does not affect PGCs *per se*. Further analysis revealed that both frequency and amplitude of sIPSCs in PGCs were elevated by DA ([Figures 3B,C](#F3){ref-type="fig"}). To determine what receptors mediate these actions, either (S)-(-)-Sulpiride (100 μM) or SKF83566 (10 μM) was bath-applied before DA addition in another set of experiments. It turned out that SKF83566 rather than (S)-(-)-Sulpiride completely blocked DA effects on sIPSCs in all tested PGCs ([Figures 3D,E](#F3){ref-type="fig"}), indicating mediation by D1LRs. Specifically, the average frequency and amplitude of sIPSCs in seven PGCs were 18.4 ± 5.0 Hz and 47.1 ± 8.7 pA in ACSF, 30.0 ± 6.8 Hz (*p* \< 0.0001 vs. in ACSF) and 72.5 ± 13.4 pA in DA (*p* \< 0.0001 vs. in ACSF), and 18.8 ± 4.8 Hz (*p* = 1 vs. in ACSF) and 47.9 ± 8.5 pA (*p* = 1 vs. in ACSF) after DA washout, respectively. In the presence of (S)-(-)-Sulpiride, average frequency and amplitude of sIPSCs in another set of six PGCs were 23.0 ± 7.5 Hz and 50.2 ± 11.0 pA, 33.6 ± 8.7 Hz (*P* \< 0.0001 vs. Sul) and 70.7 ± 14.1 pA (*P* \< 0.0001 vs. Sul) with addition of DA, 23.2 ± 7.3 Hz (*p* = 1 vs. Sul) and 51.8 ± 11.1 pA (*p* = 1 vs. Sul), respectively. However, with SKF83566 in the bath, average frequency and amplitude of sIPSCs in six PGCs were 19.5 ± 5.7 Hz and 44.6 ± 9.0 pA, 19.4 ± 5.6 Hz (*p* = 1 vs. SKF) and 44.4 ± 8.3 pA (*p* = 1 vs. SKF) with addition of DA, respectively. Similar pharmacological results of DA actions on sIPSCs were observed in both SACs and ETCs ([Figures 3F--I](#F3){ref-type="fig"}) except DA did not show significant effect on sIPSC amplitude in SACs ([Figure 3G](#F3){ref-type="fig"}), supporting our prediction that DA increases overall glomerular inhibition.

![DA enhances synaptic inhibition of glomerular neurons. **(A)** A typical trace (top) showing that bath-applied two doses of DA (20 μM) reversibly and reproducibly enhances spontaneous inhibitory postsynaptic currents (sIPSCs) in a PGC voltage clamped at 0 mV in the presence of NBQX and APV. Note that sIPSCs are completely eliminated by bath-application of the selective GABA~A~ receptor blocker gabazine (10 μM). Bottom traces are blown up from the top traces. **(B,C)** Graphs showing cumulative probability of frequency **(B)** or amplitude **(C)** of sIPSCs presented in A before (control) or during (DA) DA application, or after DA washout (wash). **(D--I)** Pooled data showing that DA significantly enhances sIPSC frequency in PGCs **(D)**, SACs **(F)**, or ETCs **(H)**, and amplitude in both PGCs **(E)** and ETCs **(I)** but not in SACs **(G)** in either control (contrl, *n* = 7 PGCs, 7 SACs, 6 ETCs) or in the presence of 100 μM (S)-(-)-Sulpiride (Sul, *n* = 6 PGCs, 7 SACs, 6 ETCs) while DA has effect on neither frequency nor amplitude of sIPSCs in all three populations of glomerular neurons in the presence of 10 μM SKF83566 (SKF, *n* = 6 PGCs, 6 SACs, 7 ETCs).](fncel-14-00172-g003){#F3}

In sum, our results demonstrate that DA enhances both frequency and amplitude of sIPSCs similarly in both PGCs and ETCs while in SACs DA increased only frequency but not amplitude of sIPSCs. Pharmacological analyses suggest that all these elevating effects in all three populations of glomerular neurons are mediated by D1LRs.

Glomerular Application of DA Augments sIPSCs in Mitral Cells (MCs) {#S3.SS3}
------------------------------------------------------------------

MCs, the principal OB output neurons, have apical dendrites ramifying in single glomeruli where they receive glomerular inhibition. Thus, it was plausible to predict that DA potentiated glomerular inhibition of MCs. To examine this possibility, we voltage clamped MCs at −0 mV in OB slices to maximize sIPSC detection in the presence of NBQX and APV. MC responses to DA (100 μM) micropuffed (30 psi for 2 ms) to the glomeruli receiving apical dendrites of the recorded cells were recorded as described previously ([@B54]). Alexa 594 (10 μM) was included in internal solution to visualize the recorded cells and their apical dendrites thus facilitate DA micropuffing ([Figure 4A](#F4){ref-type="fig"}). In these conditions, micropuffing DA reversibly increased both frequency and amplitude of sIPSCs in all tested seven MCs ([Figures 4B--F](#F4){ref-type="fig"}). The average frequency and amplitude of sIPSCs in seven cells were 42.6 ± 7.7 Hz and 32.0 ± 8.7 pA in ACSF (control), 62.0 ± 11.6 Hz (*p* \< 0.001 vs. control) and 49.6 ± 11.2 pA (*p* \< 0.001 vs. control) in DA, and 42.3 ± 7.8 Hz (*p* = 1 vs. control) and 31.1 ± 8.0 pA (*p* = 1 vs. control) after DA washout, respectively. Collectively, our results demonstrate that DA enhances glomerular inhibition of MCs.

![DA elevates glomerular inhibition in MCs. **(A)** Photo graph of a mitral cell filled with Alexa594 via patch clamp pipette in an OB slice. **(B)** The top trace shows that DA (red arrow head) micropuffed to the glomerulus receiving the apical dendrite of the recorded MC as shown in **(A)** potentiates sIPSCs in the MC voltage clamped at 0 mV. Bottom traces are blown up. **(C,D)** Plotting graph showing cumulative probability of sIPSC frequency **(C)** or amplitude **(D)** in control, in the presence of DA, and after DA washout. **(E,F)** Pooled data showing effects of the micropuffed DA on sIPSC frequency **(E)** or amplitude **(F)** in seven MCs.](fncel-14-00172-g004){#F4}

Dopamine Selectively Excites Short Axon Cells {#S3.SS4}
---------------------------------------------

Periglomerular cells and SACs are two major populations of inhibitory glomerular interneurons. To test whether DA activates them to release GABA and increase glomerular inhibition, we did both voltage and current clamp recordings from both SACs and PGCs in the presence of synaptic transmission blockers NBQX (10 μM), APV (50 μM) and GBZ (10 μM) to eliminate circuit influence. SACs responded to bath application of DA with an inward current ([Figure 5A](#F5){ref-type="fig"}) in voltage clamp (*V*~hold~ = −65 mV) or depolarization with spikes in current clamp ([Figure 5C](#F5){ref-type="fig"}) while PGCs did not respond to the same dose of DA ([Figures 5B,D](#F5){ref-type="fig"}). The average amplitude of the DA-induced inward current in five SACs was 13.0 ± 2.6 pA in ACSF and 0.2 ± 0.1 pA in the presence of SKF83566 (*p* \< 0.01 vs. in ACSF) while in five PGCs the average amplitude was 0.4 ± 0.1 pA ([Figure 5E](#F5){ref-type="fig"}). In current clamp, the average amplitude of DA-induced depolarization in five SACs was 5.1 ± 0.6 mV in ACSF and 0.3 ± 0.1 mV (*p* \< 0.01 vs. in ACSF) in the presence of SKF83566 while there was no depolarization in five PGCs (0.2 ± 0.1 mV) ([Figure 5F](#F5){ref-type="fig"}). Taken together, our results demonstrate that DA selectively excites SACs via D1LRs.

![DA directly excites SACs but not PGCs. **(A,B)** Recording traces showing that bath-applied DA produces an inward current in a SAC **(A)** but not in a PGC **(B)** when cells are voltage clamped at --60 mV in the presence of NBQX, APV and GBZ. **(C,D)** Current clamp traces showing that DA depolarizes a SAC **(C)** but not a PGC **(D)**. **(E,F)** Pooled data showing amplitude **(E)** of the DA-induced inward current or depolarization **(F)** in SACs (*n* = 5) but not in PGCs (*n* = 5). \*\*\**P* \< 0.01.](fncel-14-00172-g005){#F5}

GABA~B~ Receptors Mediate the DA Suppressive Effects on sEPSCs in Glomerular Interneurons {#S3.SS5}
-----------------------------------------------------------------------------------------

Dopamine and GABA are coreleased from SACs ([@B40]; [@B9]; [@B35]; [@B42]) whereas activation of D2LRs or GABA~B~ receptors produces presynaptic inhibition in many brain areas including the OB ([@B44]; [@B2]; [@B18]; [@B28]; [@B59]; [@B4]; [@B42]). To test whether activation of GABA~B~ receptors is required for the DA actions we observed, sEPSCs were recorded in both PGCs and SACs and their responses to DA were compared between with and without the selective GABA~B~ receptor antagonist CGP55845 (10 μM) in the bath. As shown in [Figures 6A--C](#F6){ref-type="fig"}, neither CGP55845 nor CGP55845 plus DA showed effect on sEPSCs in a PGC compared to control. Further analysis revealed DA effect on neither frequency nor amplitude of sEPSCs in six PGCs or five SACs ([Figures 6D,E](#F6){ref-type="fig"}), suggesting that activation of GABA~B~ receptors is required for the DA suppressive effects on sEPSCs in PGCs and SACs.

![Antagonizing GABA~B~ receptors eliminates DA effects on sEPSCs in glomerular interneurons. **(A)** Typical recording traces showing burst sEPSCs in a PGC before (top), during (middle) bath application of CGP55845 (CGP, 10 μM), a selective GABA~B~ receptor antagonist, or addition of DA (bottom) in the presence of CGP. **(B,C)** Graphs showing cumulative probability of frequency **(B)** or amplitude **(C)** of sEPSCs presented in **(A)**. **(D,E)** Pooled data showing that DA has effect on neither frequency **(D)** nor amplitude **(E)** of sEPSCs in either PGCs (*n* = 6) or SACs (*n* = 5) in the presence of CGP55845.](fncel-14-00172-g006){#F6}

DA Produces an Excitatory Net Effect on MCs {#S3.SS6}
-------------------------------------------

External tufted cells provide direct excitatory input to MCs and contribute to long-lasting depolarization (LLD) ([@B16]; [@B22]). Our previous study showed that DA increases ETC spontaneous spike burst frequency ([@B35]), indicating that DA increase LLD frequency. However, our present results showed that DA enhanced glomerular inhibition at least partially due to its selective activation of SACs, indicating that DA inhibits MC output. What will be the DA net effects on MC output with integration of these two directionally opposite actions? To answer this question, we first recorded MCs in voltage clamp with a holding potential at −60 mV and observed their responses to glomerular application of DA as shown by [Figures 7A,B](#F7){ref-type="fig"}. Alexa 594 (10 μM) was included in the patch pipette to visualize the recorded MC somata and their apical dendrites. In these conditions, micropuffing DA (100 μM, 2 ms) to glomeruli (off-target) next to the ones receiving the apical dendrites of the recorded cells did not evoke alteration in the spontaneous LLD (sLLD, [Figure 7C](#F7){ref-type="fig"} top traces). However, when the puffing electrode was moved to target the glomerulus innervated by the apical dendrite of the recorded cell (on-target), DA reversibly induced an inward current in MCs ([Figure 7C](#F7){ref-type="fig"} middle traces). The frequency of the spontaneous LLD superimposed on the inward current was increased compared to that before DA application ([Figure 7C](#F7){ref-type="fig"} middle blown-up traces). After bath application of the glutamatergic receptor blockers NBQX and APV, sLLDs disappeared and glomerular application of DA showed no effect on the holding current ([Figure 7C](#F7){ref-type="fig"} bottom trace), indicating that DA does not affect MC intrinsic properties and the DA-induced inward current is mediated by glutamate from ETCs. Consistently, further experiments showed that DA effects on MCs were completely blocked by SKF83566 ([Figures 7D,E](#F7){ref-type="fig"}), indicating that they are due to activation of D1LRs in ETCs ([@B35]). In seven MCs, the average amplitude of the first and second dose of DA-induced inward current was 96.8 ± 8.7 pA and 91.9 ± 8.9 pA, respectively ([Figure 7D](#F7){ref-type="fig"}). The sLLD frequency in seven MCs was increased from 0.48 ± 0.08 Hz in control to 0.83 ± 0.08 Hz by the first dose of DA but resumed to 0.49 ± 0.08 Hz after DA washout. The second dose of DA elevated this frequency to 0.78 ± 0.07 Hz (*p* \< 0.05 compared to washout of first dose of DA) followed by a recovery (0.49 ± 0.08 Hz). In sum, these voltage clamp data showed that glomerular application of DA produced an excitatory net effect on MCs via D1LRs.

![Glomerular application of DA produces an inward current and increases sLLD frequency in MCs. **(A)** Photo graph of a MC filled with Alexa594 via patch clamp pipette in an OB slice. **(B)** Diagram illustration of DA application to the glomerulus (on-target) receiving the apical dendrites of the recorded MC or its adjacent glomerulus (off-target). **(C)** Recording traces showing the rhythmic long-lasting depolarizing (LLD)/inward currents recorded in a MC voltage clamped at --60 mV and their responses to off-target (top), on-target application of DA as shown in **(B)** in control condition (middle) or in the presence of NBQX and APV to block fast glutamate receptors (bottom). Traces at expanded time scale beneath the top and middle traces show changes in LLD current frequency after DA application. **(D)** Graphs of pooled data from two groups of MCs. Data of the first group of MCs (*n* = 7) show the amplitude of the inward currents induced by the first (1st) and second (2nd) dose of DA in ACSF, in the presence of NBQX and APV (N&A). The second group of MCs (*n* = 6) show effects of two doses of DA on-target application on the holding current in the presence of SKF83566, a selective D1LR antagonist. **(E)** Pooled data from two groups of MCs. Data of the first group of MCs (*n* = 7) show the frequency of the spontaneous LLD (sLLD) currents in ACSF (control), addition of the first dose of dopamine (1st DA), washout of the first dose of DA, application of the second dose of DA (2nd DA), washout of the second dose of DA, or in the presence of NBQX and APV. Data of the second group of MCs (*n* = 6) show sLLD frequency in the presence of SKF83566 before (control) or during (DA) DA application, and after DA washout (wash).](fncel-14-00172-g007){#F7}

This conclusion led us to predict that DA enhance MC output to downstream centers. To test this, we repeated the prior experiments in current clamp ([Figures 8A,B](#F8){ref-type="fig"}). Again, off-target glomerular application of DA did not evoke significant effect on MC membrane potential or sLLD frequency ([Figure 8C](#F8){ref-type="fig"} top traces and [Figure 8E](#F8){ref-type="fig"}) while on-target DA reversibly and reliably evoked spike responses in MCs ([Figure 8C](#F8){ref-type="fig"} middle traces and [Figure 8C](#F8){ref-type="fig"}). Consistent with voltage clamp results, after treatment of OB slices with SKF83566 for 10 min, on-target DA neither elicited spike response nor affected sLLDs ([Figures 8C,E](#F8){ref-type="fig"}) whereas DA no longer showed any effect in the presence of NBQX and APV to completely block sLLDs ([Figure 8C](#F8){ref-type="fig"} bottom trace). The first dose of DA increased the average instant frequency of spikes in 10 MCs from 4.8 ± 2.4 Hz to 32.2 ± 3.8 Hz (*p* \< 0.0001) followed by a complete recovery (4.9 ± 2.4 Hz, *p* = 1 compared to pre-DA) while the second dose of DA reversibly elevated it up to 30.6 ± 4.2 Hz (*p* \< 0.0001 compared to first DA washout). These actions were completely blocked by SKF83566 ([Figure 8D](#F8){ref-type="fig"}).

![Glomerular application of DA elevates OB output from MCs. **(A)** Photo graph of a MC filled with Alexa594 via patch clamp pipette in an OB slice. **(B)** Diagram illustration of DA application to the glomerulus (on-target) receiving the apical dendrites of the recorded MC or its adjacent glomerulus (off-target). **(C)** Recording traces showing the spontaneous rhythmic long-lasting depolarization (LLD) recorded in a MC in current clamp and their responses to off-target (top) or on-target application of DA as shown in **(B)** in ACSF, in the presence of SKF83566 to block D1LRs (middle) or NBQX and APV to block fast glutamate receptors (bottom). sLLDs are completely eliminated by NBQX and APV. Blown-up traces show DA effects on sLLD frequency or spike firing in each condition. **(D)** Graphs of pooled data from 10 MCs showing effects of two doses of on-target DA on action potential (AP) frequency in ACSF or in the presence of SKF83566. **(E)** Graphs of pooled data from six MCs showing effects of two doses of off-target DA or two doses of on-target DA on sLLD frequency in the presence of SKF83566 as well as effect of NBQX and APV.](fncel-14-00172-g008){#F8}

Taken together, our results demonstrate that DA produces an excitatory net effect on MCs and consequently increases OB output to downstream olfactory centers.

Discussion {#S4}
==========

We characterized DA actions on both excitatory and inhibitory transmission in the glomerular circuit followed by analysis of the underlying cellular mechanisms and DA impact on OB output with five major findings ([Figure 9](#F9){ref-type="fig"}). First, DA via D1LRs suppresses sEPSCs in the ETC-driven inhibitory glomerular interneurons, contradicting with DA excitatory actions on ETCs. Second, activation of D1LRs potentiates sIPSCs in all glomerular neurons, indicating enhancement of glomerular inhibition. Consistently, glomerular application of DA elevates sIPSCs in MCs. Third, the depression of sEPSCs in inhibitory glomerular interneurons is blocked by inhibition of GABA~B~ receptors, implying that DA increases GABA release from inhibitory glomerular interneurons to inhibit glutamate release from ETC apical dendrites. Fourth, DA selectively excites the GABAergic SACs but not PGCs via D1LRs. Finally, DA produces a net excitatory effect on MC output via D1LRs. This effect is mediated by glutamate, suggesting the DA excitation of ETCs surpasses the enhanced glomerular inhibition thus potentiates the OB output to downstream targets.

![Schematic summarizing DA regulation of OB output through intra- and inter-glomerular circuits. In the activated glomerulus (left, red), the DA net effect on output neurons is excitatory. DA directly excites two glomerular neuron types via D1LRs: the external tufted cells (ETCs, 1a) and short axon cells (SACs, 2a). Excitation of ETCs increases MC output (1b) while excited SACs corelease GABA and DA (2b) which lead to multiple consequences: (1) GABA activates GABA~B~ receptors on ETC apical dendrites to reduce glutamate release and suppress sEPSCs in postsynaptic periglomerular cells (PGCs) and SACs (2c); (2) GABA activates GABA~A~ receptors on PGCs to reduce glomerular inhibition of MCs (disinhibition) leading to further increase in MC output (2d); (3) GABA also inhibits MCs directly, but this inhibition is surpassed by the ETC-MC pathway-derived excitation. In the neighboring or distal glomeruli (black), output neurons are inhibited mainly by GABA-mediated interglomerular action. Thus, DA enhances the system's sensitivity through a mechanism similar to center-surround inhibition.](fncel-14-00172-g009){#F9}

DA Regulates the Excitation--Inhibition Balance in the Glomerular Circuit {#S4.SS1}
-------------------------------------------------------------------------

Our previous study demonstrates that endogenous DA released from SACs or exogenous DA enhances ETC output by elevating the hyperpolarization-activated cation current (*I*~h~) ([@B35]). ETCs do not have lateral dendrites and their sole apical dendrites ramify in individual glomeruli ([@B49]; [@B39]; [@B26]; [@B1]). Thus, they are generally considered as local excitatory interneurons participating in the operation of glomerular circuit. ETC apical dendrites form glutamatergic dendrodendritic synapses with vast majority of PGCs and SACs ([@B53]; [@B30]), and apical dendrites of MTCs ([@B16]; [@B22]) so that the overall excitation level at the glomerular level has been thought to be controlled or coordinated by ETC activities ([@B16]). Subsequent studies with optogenetic approaches did not reveal endogenous DA actions on other postsynaptic targets of SACs including MTCs and PGCs ([@B3]; [@B36]; [@B55]), suggesting that DA functions as a neurotransmitter to mediate wiring transmission only from SACs to ETCs. In this context, by activating ETCs DA should increase synaptic excitation across all neuron populations in the glomerular layer. However, DA may alternatively function as a neuromodulator to mediate volume transmission given its long-lasting small quantal release from SACs ([@B14]; [@B9]). In this scenario, actions of endogenous DA released from SACs may alter synaptic activities at dendritic terminals without detectable changes in membrane current or potential at cell somata where recordings are normally made from with conventional electrophysiological approaches. In other words, DA could act on neurons other than ETCs to subtly alter the synaptic excitation--inhibition balance among distinct neuron populations. Consistently, findings of the present study support this prediction, i.e., exogenous DA excites only MTCs but not the ETC-driven inhibitory glomerular interneurons PGCs and SACs, in which DA via D1LRs decreases spontaneous excitatory synaptic activities instead. Our further analysis supports that the excitatory actions of DA on MTCs are not due to direct activation of MTCs but instead are through ETC intermediation because they are eliminated by blocking the glutamatergic receptors AMPA and NMDA receptors, which mediate the transmission from ETCs to MTCs ([@B16]; [@B22]). Thus, DA differentiates the ETC-driven MTCs from ETC-driven PGCs and SACs by resetting the ETC-derived excitatory synaptic input to postsynaptic targets. These findings are consistent with previous studies showing that:(1) DA activates ETCs ([@B35]) which provide excitatory feedforward to MTCs ([@B16]; [@B22]); (2) D1LRs are broadly expressed in the OB including the glomerular layer ([@B13]; [@B4]). Therefore, the overall impact of DA actions is to enhance the OB output by enhancing the ETC-intermediated excitatory feedforward to MTCs and weakening ETC-driven excitatory synaptic input to the local GABAergic interneurons PGCs and SACs, which provide inhibitory feedforward to MTCs.

Cellular Mechanisms Underlying DA Actions {#S4.SS2}
-----------------------------------------

Our mechanistic analysis revealed that the DA-induced suppression of excitatory synaptic activities in ETC-driven PGCs and SACs requires activation of GABA~B~ receptors. Activation of GABA~B~ receptors on OSN axon terminals inhibits glutamate releases ([@B44]; [@B2]; [@B59]; [@B42]) whereas GABA~B~ receptors are also present in OB glomerular neurons ([@B21]; [@B46]). Consistent with previous work showing that GABA~B~ receptors inhibit dendrodendritic transmission from MTCs to granule cells in the OB ([@B28]), our finding suggests that GABA released from local interneurons in response to DA activates GABA~B~ receptors on ETC apical dendrites to reduce glutamate release causing suppression of excitatory synaptic activities in postsynaptic PGCs and SACs. This interpretation is supported by our findings that DA via D1LRs augments spontaneous inhibitory synaptic activities in all glomerular neurons and MTCs, suggesting DA increases GABA release from inhibitory interneurons in the glomerular layer. Interestingly, DA selectively excites or depolarizes SACs and increases their spontaneous firing frequency without detectable effect on PGCs. Taken together, these findings lead us to conclude that DA excites SACs, which release GABA to activate GABA~B~ receptors on ETC apical dendrites and reduce glutamate release causing suppression of spontaneous excitatory synaptic activities in PGCs and SACs ([Figure 9](#F9){ref-type="fig"}). Recent studies showed that another type of inhibitory neurons termed deep short axon cells (dSACs) have processes extending into the glomerular layer ([@B20]; [@B11]). Future work needs to examine DA effect on dSACs to see if this population of interneuron are also subject to DAergic modulation.

Functional Implications {#S4.SS3}
-----------------------

Similar to other brain regions like the striatum, activation of D1LR or D2LRs produces opposite effects on olfactory processing ([@B63]). In contrast to activation of D2LRs that generally produces inhibitory effects on odor discrimination and transmission of the first synapse from OSNs to postsynaptic targets in the OB ([@B45]; [@B2]; [@B18]; [@B63]; [@B57]; [@B19]; [@B42]), activation of D1LRs improves odor detection and discrimination ([@B17]; [@B63]). Consistently, our findings in the present study show that overall net effect of DA on OB output is the D1LR-mediated excitation, which depolarizes the output neurons MTCs to bring their resting membrane potential closer to the threshold of action potential generation, meanwhile, activation of D1LRs selectively excites SACs. Since SACs have long processes connecting multiple glomeruli ([@B32]; [@B30]), DA activation of SACs is speculated to extend inhibition to ETCs ([@B35]; [@B60]) and output neurons ([@B3]; [@B36]) in neighboring or distal glomeruli. Thus, we propose that activation of D1LRs is to produce a center-surrounding effect thus enhances OB output from the activated glomeruli to facilitate odor detection and discrimination. Further work by knocking out D1LRs or chemogenetic inhibition of D1LRs in the OB would provide insight into this speculation.
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